Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use
Open Access
- 13 June 2022
- journal article
- research article
- Published by Taylor & Francis in Gut Microbes
- Vol. 14 (1) , 2083905
Abstract
Detrimental consequences of antibiotic treatment may include long-lasting disruption of the gut microbiota. Previous studies found no negative effects of antibiotics on metabolic health, although individualized responses were observed. Here, we aimed to investigate the subject-specific response to vancomycin use in tissue-specific insulin sensitivity by stratifying individuals based on the presence of antibiotic resistance genes (ARGs) or opportunistic pathogens (OPs) in the baseline fecal microbiota. Quantitative Polymerase Chain Reaction (qPCR) was used to detect ARGs and OPs in DNA isolated from fecal samples of 56 males with overweight/obesity (Body Mass Index: 25–35 kg/m2) and impaired glucose metabolism (fasting plasma glucose ≥5.6 mmol/L and/or 2-hour glucose 7.8–11.1 mmol/L). A two-step hyperinsulinemic-euglycemic clamp was performed to determine tissue-specific insulin sensitivity. Abdominal subcutaneous adipose tissue (AT) gene expression was assessed using Affymetrix microarray. Gut microbial composition was determined using the Human Intestinal Tract Chip (HITChip) microarray. At baseline, the vancomycin resistance gene vanB was present in 60% of our population. In individuals that were vanB-negative at baseline, AT insulin sensitivity (insulin-mediated suppression of plasma free fatty acids) improved during vancomycin use, while it decreased among vanB-positive individuals (% change post versus baseline: 14.1 ± 5.6 vs. −6.7 ± 7.5% (p = .042)). The vancomycin-induced increase in AT insulin sensitivity was accompanied by downregulation of inflammatory pathways and enrichment of extracellular matrix remodeling pathways in AT. In the vanB-positive group, well-known vanB-carrying bacteria, Enterococcus and Streptococcus, expanded in the gut microbiome. In conclusion, microbiome composition and adipose tissue biology were differentially affected by vancomycin treatment based on fecal vanB carriage.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- TIFood and Nutrition public private partnership (GH003)
This publication has 39 references indexed in Scilit:
- Antibiotic Resistance: A Primer and Call to ActionHealth Communication, 2014
- Development of a Multiplex Real-Time PCR for the Rapid Detection of the Predominant Beta-Lactamase Genes CTX-M, SHV, TEM and CIT-Type AmpCs in EnterobacteriaceaePLOS ONE, 2014
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivityJournal of Hepatology, 2014
- Intestinal Commensal Microbes as Immune ModulatorsCell Host & Microbe, 2012
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences, 2010
- Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adultsEnvironmental Microbiology, 2009
- Quantification ofBifidobacteriumspp.,Escherichia coliandClostridium difficilein faecal samples of breast-fed and formula-fed infants by real-time PCRFEMS Microbiology Letters, 2005
- Quantification of Bacteria Adherent to Gastrointestinal Mucosa by Real-Time PCRJournal of Clinical Microbiology, 2002
- Vancomycin-Resistant EnterococciClinical Microbiology Reviews, 2000
- VancomycinMayo Clinic Proceedings, 1991